ID: ALA5280274

Max Phase: Preclinical

Molecular Formula: C16H14O3

Molecular Weight: 254.28

Associated Items:

Representations

Canonical SMILES:  COc1ccc2c(c1)C/C(=C\c1ccc(C)o1)C2=O

Standard InChI:  InChI=1S/C16H14O3/c1-10-3-4-14(19-10)9-12-7-11-8-13(18-2)5-6-15(11)16(12)17/h3-6,8-9H,7H2,1-2H3/b12-9+

Standard InChI Key:  IEJAVDWNSNDMRX-FMIVXFBMSA-N

Associated Targets(Human)

Monoamine oxidase B 8835 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 254.28Molecular Weight (Monoisotopic): 254.0943AlogP: 3.42#Rotatable Bonds: 2
Polar Surface Area: 39.44Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.99CX LogD: 2.99
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.77Np Likeness Score: -0.54

References

1. Guglielmi P, Mathew B, Secci D, Carradori S..  (2020)  Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors.,  205  [PMID:32920430] [10.1016/j.ejmech.2020.112650]

Source